Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-24 @ 11:41 PM
NCT ID:
NCT01770951
Eligibility Criteria:
Inclusion Criteria:
1. Male or female patients of any age who have been diagnosed with aHUS.
2. Received at least one dose of eculizumab for the treatment of aHUS between 2007 and 2009 outside of an Alexion sponsored controlled clinical trial.
Exclusion Criteria:
1\. Patients who have participated or are currently participating in a controlled clinical trial of eculizumab
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01770951
Study Brief:
Protocol Section:
NCT01770951